The proportion of elderly people in the world population is constantly increasing. With age,
the risk of numerous chronic diseases and their complications also rises. Research on the …

Recent studies report a significant age-specific increase in hepatocellular carcinoma (HCC)
development among persons over 75 years old. Therefore, there is an urgent need to …

Hepatocellular carcinoma (HCC), is the sixth most frequent form of cancer and leads to the
fourth highest number of deaths each year. HCC results from a combination of …

AIM: To conduct a meta-analysis to investigate the clinical outcomes of surgical resection
and locoregional treatments for hepatocellular carcinoma (HCC) in elderly patients defined …

Hepatocellular carcinoma (HCC) is the second most common cause of death by cancer in
the world. Due to the delayed HCC development in hepatitis C carriers and nonalcoholic …

Aims This study was performed to investigate the effect of PD-L1 polymorphisms on the
susceptibility and prognosis of hepatocellular carcinoma (HCC) in a Chinese Han …

In view of the increasing life expectancy in different parts of the world, a larger proportion of
elderly patients with hepatocellular carcinoma (HCC) requiring oncological treatment is …

Objectives: Radiofrequency ablation plays a key role in the treatment of early-stage
hepatocellular carcinoma. However, it is not recommended for intermediate-stage …

For hepatocellular carcinoma (HCC) patients with macrovascular invasion (MaVI),
hepatectomy and transcatheter arterial chemoembolization (TACE) remain the main …

Hepatocellular carcinoma (HCC) is a major health problem worldwide. The average life
expectancy during the 20th century has increased in many parts of the world, and therefore …